Virus News and Research

Latest Virus News and Research

UC Davis researchers awarded $1.5 million NIH grant for CRISPR cancer treatment

What if, instead of killing cancer cells or cells about to become cancerous, you could deliver a repair package and fix them? UC Davis researchers have just been awarded $1.5 million from the National Institutes of Health to start work towards that goal.

3 Oct 2019

High-resolution imaging shows how HIV spreads between living cells

In order to treat diseases better, we must understand how they arise.

3 Oct 2019

Researchers make breakthrough in gene therapy for sickle cell disease

Researchers at the National Institutes of Health have developed a new and improved viral vector--a virus-based vehicle that delivers therapeutic genes--for use in gene therapy for sickle cell disease.

2 Oct 2019

Maternal exposure to pollutants can lead to multigenerational weakening of the immune system

New research shows that maternal exposure to a common and ubiquitous form of industrial pollution can harm the immune system of offspring and that this injury is passed along to subsequent generations, weakening the body's defenses against infections such as the influenza virus.

2 Oct 2019

New study shows response to HIV vaccine in 6 weeks

A US study on DNA-based and protein HIV vaccines has shown that an antibody and cellular immune response occurs within six weeks.

2 Oct 2019

New study shows response to HIV vaccine in 6 weeks

A new study using DNA-based and protein HIV vaccines in various combinations shows that antibody and cellular immune response occurs within 6 weeks from the date of vaccination, and the combination must be administered together for the most rapid protection. This will enable more large-scale testing of the vaccine for effectiveness. About 40 million people today have HIV infections, and 1.2 million deaths a year are related to this infection.

1 Oct 2019

US Government to fund development of a 'universal flu vaccine'

The US government is to provide up to 400 million USD in funding to develop a “universal” flu vaccination at Duke University over the next seven years.

1 Oct 2019

Mount Sinai researchers receive NIH award to develop universal flu vaccine

Researchers at the Icahn School of Medicine at Mount Sinai have received a contract award of up to $132 million from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH), as part of a new Collaborative Influenza Vaccine Innovation Centers (CIVICs) program to further develop the universal flu vaccine.

1 Oct 2019

NIAID initiates new Collaborative Influenza Vaccine Innovation Centers program

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has initiated the Collaborative Influenza Vaccine Innovation Centers program, a new network of research centers that will work together in a coordinated, multidisciplinary effort to develop more durable, broadly protective and longer-lasting influenza vaccines.

30 Sep 2019

University of Georgia signs contract with NIH to develop advanced influenza vaccine

The University of Georgia has signed a contract with the National Institutes of Health for an initial award of $8 million to develop a new, more advanced influenza vaccine designed to protect against multiple strains of influenza virus in a single dose.

30 Sep 2019

New CRISPR-Cas9 variant has potential to increase precision during gene therapy

Researchers have developed a new variant of the gene editing technique CRISPR-Cas9 that has the potential to increase precision during gene therapy in humans.

30 Sep 2019

Infectious disease experts explain how to stay healthy during the flu season

About 40 million people contracted the flu last year, with hundreds of thousands hospitalized and 35,400 to 61,000 deaths, including 134 children, according to the Centers for Disease Control and Prevention.

30 Sep 2019

Duke Human Vaccine Institute participates in a large national effort to improve flu shots

As part of a massive national effort to improve and modernize flu shots, the Duke Human Vaccine Institute has received three research contracts from the National Institute of Allergy and Infectious Diseases, with an initial award of approximately $29.6 million in first-year funding.

30 Sep 2019

Novel immunotherapy combination could provide fresh hope for patients with cervical cancer

With an estimated 570,000 cases and 311,000 deaths in 2018 worldwide, cervical cancer currently ranks as the fourth most frequently diagnosed cancer and the fourth leading cause of cancer death in women.

30 Sep 2019

Johns Hopkins researchers develop new way to deliver sight-saving gene therapy to the retina

In experiments with rats, pigs and monkeys, Johns Hopkins Medicine researchers have developed a way to deliver sight-saving gene therapy to the retina.

From Johns Hopkins Medicine 30 Sep 2019

UK government considers compulsory immunization for all school children

Immunization efforts have been implemented across the globe. But, the rates of immunized children are dropping. In the United Kingdom, health officials have expressed alarms the drop in take-up of routine childhood vaccinations, leaving thousands of children under-protected from 13 different diseases.

30 Sep 2019

Scientists discover T cell homing beacons for lungs

Scientists have identified a pair of molecules critical for T cells, part of the immune system, to travel to and populate the lungs. A potential application could be strengthening vaccines against respiratory pathogens such as influenza.

27 Sep 2019

WHO begins emergency vaccination campaign to slow measles outbreak in DR Congo

The WHO and government of the DR Congo have begun an emergency vaccination program to stop the spread of measles in the country.

27 Sep 2019

Research reveals why viruses will need to be reclassified and its biotech impact

New research reveals that the way viruses were perceived in terms of their architecture will need to be retooled, because they are actually structured in many more patterns than previously understood.

27 Sep 2019

Study provides new insights on how influenza virus achieves efficient viral RNA replication

New insights on how subunits of the influenza virus polymerase co-evolve to ensure efficient viral RNA replication are provided by a study published October 3 in the open-access journal PLOS Pathogens by Nadia Naffakh of the Institut Pasteur, and colleagues. As the authors note, the findings could lead to novel strategies for antiviral drug development.

From PLOS ONE 27 Sep 2019

Virus News and Research

Latest Virus News and Research

UC Davis researchers awarded $1.5 million NIH grant for CRISPR cancer treatment

High-resolution imaging shows how HIV spreads between living cells

Researchers make breakthrough in gene therapy for sickle cell disease

Maternal exposure to pollutants can lead to multigenerational weakening of the immune system

New study shows response to HIV vaccine in 6 weeks

New study shows response to HIV vaccine in 6 weeks

US Government to fund development of a 'universal flu vaccine'

Mount Sinai researchers receive NIH award to develop universal flu vaccine

NIAID initiates new Collaborative Influenza Vaccine Innovation Centers program

University of Georgia signs contract with NIH to develop advanced influenza vaccine

New CRISPR-Cas9 variant has potential to increase precision during gene therapy

Infectious disease experts explain how to stay healthy during the flu season

Duke Human Vaccine Institute participates in a large national effort to improve flu shots

Novel immunotherapy combination could provide fresh hope for patients with cervical cancer

Johns Hopkins researchers develop new way to deliver sight-saving gene therapy to the retina

UK government considers compulsory immunization for all school children

Scientists discover T cell homing beacons for lungs

WHO begins emergency vaccination campaign to slow measles outbreak in DR Congo

Research reveals why viruses will need to be reclassified and its biotech impact

Study provides new insights on how influenza virus achieves efficient viral RNA replication

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Newsletters you may be interested in